Fidaxomicin: Difference between revisions

(Add AntibioticDose SMW query table for dynamic indications by disease)
 
Line 7: Line 7:
==Adult Dosing==
==Adult Dosing==
*[[C. diff]] diarrhea: 200mg PO BID x 10d
*[[C. diff]] diarrhea: 200mg PO BID x 10d
===Indications by Disease===
{{#ask: [[Has DrugName::Fidaxomicin]] [[Has Population::Adult]]
|?Treats disease=Disease
|?Has Dose=Dose
|?Has Context=Context
|format=table
|limit=50
|mainlabel=-
|headers=show
|sort=Treats disease
}}


==Pediatric Dosing==
==Pediatric Dosing==
''Safety/efficacy not established''
''Safety/efficacy not established''
===Indications by Disease===
{{#ask: [[Has DrugName::Fidaxomicin]] [[Has Population::Pediatric]]
|?Treats disease=Disease
|?Has Dose=Dose
|?Has Context=Context
|format=table
|limit=50
|mainlabel=-
|headers=show
|sort=Treats disease
}}


==Special Populations==
==Special Populations==

Latest revision as of 20:38, 20 March 2026

Administration

  • Type: Macrolide antibiotic
  • Dosage Forms:
  • Routes of Administration: PO
  • Common Trade Names:

Adult Dosing

  • C. diff diarrhea: 200mg PO BID x 10d

Indications by Disease

DiseaseDoseContext
Clostridium difficile200 mg PO two times daily for 10 daysNon-Severe
Clostridium difficile200 mg PO two times daily for 10 daysSevere

Pediatric Dosing

Safety/efficacy not established

Indications by Disease

DiseaseDoseContext
Clostridium difficile200mg PO BID x 10 days (>12yr and >40kg); weight-based for youngerPediatric Non-Severe (>6 months)

Special Populations

Pregnancy Rating

  • Category B

Lactation risk

  • Infant risk cannot be ruled out

Renal Dosing

  • No adjustment

Hepatic Dosing

  • Not established

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life: ~12h
  • Metabolism: Intestinal
  • Excretion: Fecal

Mechanism of Action

  • Macrolide: inhibits RNA polymerases primarily against clostridia species

Comments

See Also

References